
Dr. Benjamin H. Krasne, M.D.
Board-certified physicianBoard-certified in anesthesiology, he reads medications and metabolism with a pharmacologist's eye, which shapes how he doses weight loss and longevity care.
Weight loss
GLP-1 shots, daily pills and non-GLP-1 options, prescribed after a free visit.
Start here
Brand-name injections
Pills and other options
Tap your state
State rules change what we can offer and how fast. Pick yours.
ESA and PSD letters, semaglutide, tirzepatide and medical card pages for every state we serve.
Popular ESA cities
Mobile IV in California
Weekly semaglutide, compounded for you
Compounded semaglutide is made for an individual patient by a licensed U.S. compounding pharmacy. It is not FDA-approved, so it pays to understand what that means before you start.
Free to book. You pay only if you go ahead with treatment.
Your clinician walks you through brand and compounded options side by side, including FDA status and cost, so you can choose with the full picture.
If treatment is appropriate, your prescription goes to a licensed U.S. compounding pharmacy. Compounded semaglutide is not FDA-approved, and we tell you so up front.
You get plain-language instructions in both units and milligrams, plus habits that help prevent the measuring mistakes the FDA has warned about.
Follow-up visits cover dose changes, side effects and refills, and your care team keeps track of changing compounding rules so you don't have to.
Pick phone or video and share your history, current medicines and goals in a short intake.
In 5–10 minutes a licensed U.S. clinician compares brand and compounded semaglutide with you and decides what is appropriate.
If prescribed, a licensed U.S. compounding pharmacy prepares it for you and labels the dose in both milligrams and syringe units.
Check the label against your instructions before every dose. Report side effects at each check-in as your dose rises.
Generally a BMI of 30 or more, or 27 or more with a condition such as high blood pressure, prediabetes or sleep apnea.
Federal rules limit copies of commercially available drugs, so your clinician records why a compounded preparation suits you, such as a dose adjustment.
You need to draw up a measured amount each week and follow the label exactly.
Skip it with medullary thyroid cancer (yours or a family member's) or MEN 2, during pregnancy, or if you prefer an FDA-approved product.
| Feature | Compounded semaglutide | Wegovy (brand semaglutide) |
|---|---|---|
| FDA status | Not FDA-approved | FDA-approved |
| Made by | Licensed U.S. compounding pharmacy | Novo Nordisk |
| Form | Vial with syringe | Prefilled pen or daily tablet |
| Measuring a dose | Draw to the unit mark on your label | Preset doses |
| Price | $149/mo | From $199/mo; brand medication may cost extra |
Compounding is when a licensed pharmacist prepares a medication for a specific patient from a prescription, rather than dispensing a factory-made product. Compounded semaglutide is usually supplied as a liquid in a vial that you draw into a syringe and inject once a week.
Because it is compounded, the FDA does not review it for safety, effectiveness or quality before it reaches you. Brand products such as Wegovy and Ozempic went through that review; compounded versions did not. That does not make every compounded product unsafe, but it does mean the pharmacy you use, and how carefully you measure each dose, matter a great deal.
Your clinician will tell you plainly whether a compounded option is available and appropriate for you, how it compares with FDA-approved semaglutide, and what to do if your situation changes.
During the national shortage of semaglutide injections, pharmacies had more room to compound it. The FDA determined that shortage was resolved on February 21, 2025, and the grace periods for compounders have since ended.
Today, state-licensed 503A pharmacies may still compound for an individual patient based on a prescription, but making what the FDA calls essentially copies of a commercially available drug is restricted. A prescriber can document a significant clinical difference for a specific patient. Larger 503B outsourcing facilities face tighter limits, and in April 2026 the FDA proposed excluding semaglutide from the list of bulk substances they may use. That proposal had not been finalized when this page was reviewed.
These rules can change. Your clinician and pharmacy keep track of them so you do not have to.
The FDA has received reports of people hospitalized after dosing errors with compounded semaglutide, often from confusing milligrams, milliliters and syringe units. A few habits prevent most of these mistakes.
Compounded semaglutide shares the known risks of the semaglutide molecule, plus risks that come from compounding itself, such as dosing errors and variation between pharmacies.
Independently licensed U.S. physicians supervise every treatment we offer.

Board-certified in anesthesiology, he reads medications and metabolism with a pharmacologist's eye, which shapes how he doses weight loss and longevity care.

Trained at Columbia and Washington University, he pairs prescriptions with practical habits around food, training and sleep.

An OB-GYN for more than 40 years and a Fellow of ACOG, she leads women's health care, from perimenopause to PCOS.
Still deciding? The first consultation is free and takes about 5–10 minutes.
Book a free consultationNo. Compounded drugs are not FDA-approved, and the FDA does not check them for safety, effectiveness or quality before they are dispensed. Brand products such as Wegovy and Ozempic are FDA-approved.
State-licensed pharmacies may compound for individual patients with a prescription. Copies of commercially available drugs are restricted, but a prescriber can document a significant clinical difference for a particular patient. Your clinician explains whether that applies to you.
A 503A pharmacy is a state-licensed pharmacy that compounds for specific patients based on prescriptions. A 503B outsourcing facility registers with the FDA and can make larger batches, but it faces strict limits on which bulk ingredients it may use. In April 2026, the FDA proposed keeping semaglutide off the bulk substances list for 503B facilities; a final decision was still pending when this page was reviewed.
They are salt forms that some compounders have used. The FDA says they are different active ingredients from the one in approved products and that it knows of no lawful basis for compounding with them. It is reasonable to ask your pharmacy which form it uses.
Compounded semaglutide comes as a liquid, and insulin-style syringes are marked in units rather than milligrams. How many units equal your dose depends on the vial's concentration. Always follow the unit number on your current label.
Some pharmacies add B12 to compounded semaglutide. There is no FDA-approved semaglutide product with B12, and the FDA has said adding another ingredient does not automatically make a product something other than a copy. Your clinician can tell you whether it adds anything for you.
Follow the storage directions on your pharmacy label, which usually call for refrigeration. Do not freeze it, keep it away from light, and throw it out by the beyond-use date printed on the label.
Doses are expressed in milligrams just like Wegovy, but the liquid concentration and the way you measure it differ. Your clinician sets a schedule that climbs gradually, similar in shape to brand dosing.
Yes, if your clinician agrees it is appropriate. Because the ingredient is the same, they can usually choose a sensible starting point on the brand product. Brand medication may cost more.
Legitimate compounded semaglutide always requires a prescription. Websites selling it without one, or selling products labeled for research use, are not a safe source. The FDA has warned about unapproved GLP-1 products sold this way.
The program price is $149/mo. Your clinician confirms exactly what is included and the total cost before anything is prescribed, so there are no surprises.
Call your clinician or Poison Control at 1-800-222-1222 right away. Severe nausea, vomiting, dizziness or signs of low blood sugar after a possible overdose need prompt medical care.
Book a free 5–10 minute phone or video visit. A licensed clinician will review brand and compounded options with you, and plans are $149/mo if treatment is appropriate.
Medically reviewed October 2026. This page is general information and not a substitute for advice from your own clinician. Read our editorial policy.